Literature DB >> 10738310

Characterization of chromosome 1 abnormalities in malignant melanomas.

D Smedley1, S Sidhar, S Birdsall, D Bennett, M Herlyn, C Cooper, J Shipley.   

Abstract

Chromosome 1 abnormalities are the most commonly detected aberrations in many cancers including malignant melanomas. Specific breakpoints are reported for malignant melanomas throughout the chromosome but especially at 1p36 and at several sites throughout 1p22-q21. In addition, partial deletions and loss of heterozygosity have been found on 1p indicating the possible location of tumor suppressor genes. Here we have characterized the involvement of chromosome 1 in a series of seven malignant melanoma cell lines. Initial chromosome painting studies revealed that six of the cell lines had chromosome 1 rearrangements. Deletions involving 1p10-32, 1q11-44, and 1q25-44 were observed. The other rearrangement breakpoints included three in the 1q10-p11 region with the rest at 1p36, 1p34, 1p32, 1p31, 1p12-13, 1q21, and 1q23. The breaks at 1q10-p11 were investigated further using an alpha-satellite 1 centromere probe and yeast artificial chromosomes (YACs) from the region. Two of the 1q10-p11 breaks mapped in the centromeric region, while the others mapped to variable sites. This suggests that the role of these rearrangements in the pathogenesis of melanomas does not involve the alteration of specific oncogenes in the breakpoint region. During the YAC mapping a previously undetected, small (<1 Mbp) del(1)(p10p11) was identified. This deletion lies within minimal overlapping deleted regions reported in head and neck as well as breast carcinomas and it could therefore facilitate the isolation of a carcinoma-associated tumor suppressor gene. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10738310     DOI: 10.1002/(sici)1098-2264(200005)28:1<121::aid-gcc14>3.0.co;2-o

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  21 in total

Review 1.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

2.  Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells.

Authors:  Dan Su; Xiaoying Fu; Songqing Fan; Xiao Wu; Xin-Xin Wang; Liya Fu; Xue-Yuan Dong; Jianping Jenny Ni; Li Fu; Zhengmao Zhu; Jin-Tang Dong
Journal:  Am J Pathol       Date:  2012-03       Impact factor: 4.307

3.  Ribosomal 18 S RNA processing by the IGF-I-responsive WDR3 protein is integrated with p53 function in cancer cell proliferation.

Authors:  Mary McMahon; Verónica Ayllón; Kostya I Panov; Rosemary O'Connor
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

4.  Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells.

Authors:  Weilin Wang; Jianju Lu; Feng Zhu; Jianfeng Wei; Changku Jia; Yuanbiao Zhang; Lin Zhou; Haiyang Xie; Shusen Zheng
Journal:  Med Oncol       Date:  2010-12-29       Impact factor: 3.064

5.  Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells.

Authors:  Shunsuke Noguchi; Takashi Mori; Yusami Otsuka; Nami Yamada; Yuki Yasui; Junya Iwasaki; Minami Kumazaki; Kohji Maruo; Yukihiro Akao
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

6.  Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.

Authors:  Juliet Rashidian; Erwan Le Scolan; Xiaodan Ji; Qingwei Zhu; Melinda M Mulvihill; Daniel Nomura; Kunxin Luo
Journal:  Sci Signal       Date:  2015-02-10       Impact factor: 8.192

Review 7.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

Review 8.  The hallmarks of cancer: a long non-coding RNA point of view.

Authors:  Tony Gutschner; Sven Diederichs
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

9.  Low expression of LOC285194 is associated with poor prognosis in colorectal cancer.

Authors:  Peng Qi; Mi-die Xu; Shu-juan Ni; Dan Huang; Ping Wei; Cong Tan; Xiao-yan Zhou; Xiang Du
Journal:  J Transl Med       Date:  2013-05-16       Impact factor: 5.531

10.  Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets.

Authors:  Josane F Sousa; Enilza M Espreafico
Journal:  BMC Cancer       Date:  2008-01-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.